...
首页> 外文期刊>AJRI: American Journal of Reproductive Immunology >Alterations in RCAS1 Serum Concentration Levels During the Normal Menstrual Cycle and the Lack of Analogical Changes in Ovarian Endometriosis.
【24h】

Alterations in RCAS1 Serum Concentration Levels During the Normal Menstrual Cycle and the Lack of Analogical Changes in Ovarian Endometriosis.

机译:正常月经周期中RCAS1血清浓度水平的改变以及卵巢子宫内膜异位症缺乏类似的变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Problem The selective suppression phenomenon of the cytotoxic immune response may be brought about by an increase in sRCAS1 blood serum concentration. Such an increase has been observed during cancer progression and decidualization. The aim of this study has been to evaluate alterations in RCAS1 blood serum concentration in women during normal menstrual cycle (NMC) phases and to compare the levels found with those in patients with ovarian endometriosis. Method of study The sRCAS1 blood serum concentration level was determined for both 147 patients with ovarian endometriosis and a healthy control group. Results Fluctuations in sRCAS1 blood serum concentration levels correlating with the NMC phases were demonstrated. The highest level of sRCAS1 was found during menstruation and the lowest during the proliferative cycle phase. However, no such fluctuations correlating with menstrual cycle phases were observed in the patients with endometriosis. The level of sRCAS1 in patients with endometriosis remained almost constant. Moreover, the sRCAS1 blood serum concentration level has been shown to increase, as ovarian endometriosis progresses. Conclusion RCAS1 blood serum concentration may be a useful indicator of the selective suppression of the immune cytotoxic cell phenomenon associated with the development of endometriosis.
机译:问题sRCAS1血清浓度的升高可能导致细胞毒性免疫反应的选择性抑制现象。在癌症进展和蜕膜化期间已经观察到这种增加。这项研究的目的是评估女性在正常月经周期(NMC)阶段的RCAS1血清浓度的变化,并比较发现的水平与卵巢子宫内膜异位症患者的水平。研究方法测定了147例卵巢子宫内膜异位症患者和健康对照组的sRCAS1血清浓度水平。结果证实了与NMC阶段相关的sRCAS1血清浓度水平的波动。在月经期间发现最高的sRCAS1水平,而在增生周期阶段则最低。然而,在子宫内膜异位症患者中未观察到与月经周期阶段相关的这种波动。子宫内膜异位症患者的sRCAS1水平几乎保持恒定。此外,随着卵巢子宫内膜异位症的进展,sRCAS1血清浓度已显示增加。结论RCAS1血清浓度可能是选择性抑制与子宫内膜异位症相关的免疫细胞毒性细胞现象的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号